The generic industry should have a better indication Aug. 9 of where FDA stands and could go on the subject of tablet scoring.
Members of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology will consider a number of potential tablet coring requirements during the morning session that are part of a draft...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?